Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$12.78 - $23.74 $12,907 - $23,977
-1,010 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$12.85 - $16.2 $321 - $405
25 Added 2.54%
1,010 $15,000
Q1 2021

May 13, 2021

SELL
$13.84 - $17.8 $346 - $445
-25 Reduced 2.48%
985 $14,000
Q4 2020

Feb 12, 2021

BUY
$12.4 - $17.6 $8,580 - $12,179
692 Added 217.61%
1,010 $15,000
Q3 2020

Nov 13, 2020

BUY
$11.59 - $14.93 $3,685 - $4,747
318 New
318 $4,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.